Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis
Clinical trial NCT03334851 · COMPLETED
Trial details
- NCT number
- NCT03334851
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-17
- Primary completion
- 2022-02-15
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.